Work

Solving the Problem of γ-Retroviral Vectors Containing Long Terminal Repeats

Year: 2011
Type: article
Abstract: Results from a clinical gene transfer trial for the X-linked hematological disorder Wiskott–Aldrich syndrome (WAS), carried out by Klein and colleagues at Hannover Medical School in Germany, were reported in the 11 November 2010 issue of the New England Journal of Medicine.1 The article described the clinical outcome and three-year follow-up of two young boys treated with autologous CD34+ cells transduced with a γ-retroviral vector encoding the WAS protein. Following submyeloablative conditioning, long-term engraftment levels of vector-modified CD34+ cells of 9% and 20% were observed in the bone marrow of the two patients, with similar or higher levels of corrected cells found in multiple peripheral blood hematopoietic lineages.
Language: English
Subfield: Genetics
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W1977910761
FWCI: 2.631
Cites: 16
Cited by: 34
Related to: 10